Literature DB >> 14521210

Percutaneous image-guided radiofrequency ablation of renal malignancies.

Ronald J Zagoria1.   

Abstract

There is a growing body of experience supporting the use of image-guided RFA for the treatment of primary RCC. Because surgical resection is a technique with low mortality, and a proved success rate that is high, this must remain standard therapy for patients with potentially curable RCC. Some patients with low-stage RCC, however, may not be surgical candidates. Image-guided RFA is an option for treatment of these patients. In addition, image-guided RFA shows promise for the successful care of other patients with RCC. In particular, RFA has been used successfully for the treatment of intractable hematuria resulting from an RCC; local recurrences of RCC, both for attempted cure and for palliation of symptoms; and finally for the treatment of isolated metastases from RCC. As with the treatment of primary RCC, the data remain limited for these applications. This technique should be reserved until after standard therapies have been exhausted. It seems likely that some form of image-guided percutaneous tumor therapy, such as RFA, will become an alternative treatment modality in some patients with potentially curable RCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521210     DOI: 10.1016/s0033-8389(03)00074-5

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

1.  Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney.

Authors:  Timothy M Baran; Jeremy D Wilson; Soumya Mitra; Jorge L Yao; Edward M Messing; David L Waldman; Thomas H Foster
Journal:  J Biomed Opt       Date:  2012-09       Impact factor: 3.170

Review 2.  [RFA of bone and soft tissue tumors].

Authors:  T F Jakobs; R T Hoffmann; C Vick; A Wallnöfer; M F Reiser; T K Helmberger
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

3.  CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies.

Authors:  Gero Wieners; Maciej Pech; Malgorzata Rudzinska; Lukas Lehmkuhl; Waldemar Wlodarczyk; Alexandra Miersch; Susanne Hengst; Roland Felix; Peter Wust; Jens Ricke
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 7.034

4.  Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.

Authors:  Tze M Wah; Henry C Irving; Walter Gregory; Jon Cartledge; Adrian D Joyce; Peter J Selby
Journal:  BJU Int       Date:  2013-10-22       Impact factor: 5.588

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.